XML 115 R75.htm IDEA: XBRL DOCUMENT v3.20.1
SHAREHOLDERS' EQUITY - Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Apr. 26, 2017
Feb. 13, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
STOCK BASED COMPENSATION            
Stock options granted (in shares)     3,050,000 375,000 338,000  
Exercise price of options granted (in dollars per share)     $ 1.73 $ 1.90 $ 2.99  
Exercisable period of options     1 year 2 months 12 days      
Number of common stock reserved for issuance     17,500,000      
Number of shares of common stock reserved for issuance     4,221,023 5,776,483    
Common stock issued     400,339,000 344,560,000    
Maximum number of shares that may be subject to grants of options to an individual in a calendar year     1,000,000      
Shares            
Balance at the beginning of the period (in shares)     4,243,000 4,906,000 4,720,000  
Granted (in shares)     3,050,000 375,000 338,000  
Exercised (in shares)     (535,000) (171,000) (94,000)  
Forfeited (in shares)     (700,000) (405,000) (37,000)  
Expired (in shares)     (789,000) (462,000) (21,000)  
Balance at the end of the period (in shares)     5,269,000 4,243,000 4,906,000 4,720,000
Exercisable at the end of the period (in shares)     2,234,000      
Weighted Average Exercise Price            
Balance at the beginning of the period (in dollars per share)     $ 2.33 $ 2.45 $ 2.41  
Granted (in dollars per share)     1.73 1.90 2.99  
Exercised (in dollars per share)     $ 1.01 $ 1.02 $ 1.30  
Proceeds from exercise of stock options     $ 544 $ 192 $ 121  
Forfeited (in dollars per share)     $ 2.56 $ 3.99 $ 4.28  
Expired (in dollars per share)     2.90 2.27 5.00  
Balance at the end of the period (in dollars per share)     2.00 $ 2.33 $ 2.45 $ 2.41
Exercisable (in dollars per share)     $ 2.27      
Weighted Average Remaining Contractual Life            
Outstanding at the end of the period     3 years 2 years 2 years 7 months 6 days 3 years 4 months 24 days
Exercisable period of options     1 year 2 months 12 days      
Intrinsic Value            
Outstanding at the beginning of the period (in dollars)     $ 1,475 $ 2,564 $ 4,388  
Exercised (in dollars)     419 195 87  
Outstanding at the end of the period (in dollars)     364 $ 1,475 $ 2,564 $ 4,388
Exercisable at the end of the period (in dollars)     $ 364      
Granted (in shares)     3,050,000 375,000 338,000  
Equity Incentive Plan            
STOCK BASED COMPENSATION            
Common stock issued     535,000 171,000    
Weighted Average Exercise Price            
Exercised (in dollars per share)     $ 1.02 $ 1.02    
Proceeds from exercise of stock options     $ 500 $ 200    
Lexam VG Gold            
STOCK BASED COMPENSATION            
Share replacement awards $ 100          
Ratio of Company's share for acquired company's share   0.056%        
Certain employees and directors            
STOCK BASED COMPENSATION            
Stock options granted (in shares)     3,100,000 400,000 300,000  
Exercise price of options granted (in dollars per share)     $ 1.73 $ 1.90 $ 2.99  
Shares            
Granted (in shares)     3,100,000 400,000 300,000  
Weighted Average Exercise Price            
Granted (in dollars per share)     $ 1.73 $ 1.90 $ 2.99  
Intrinsic Value            
Granted (in shares)     3,100,000 400,000 300,000  
Vesting period of options     3 years      
Exercise period of options     5 years